William Fodor
Chief Tech/Sci/R&D Officer at HARVARD APPARATUS REGENERATIVE TECHNOLOGY INC.
Net worth: - $ as of 2024-04-29
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| David Green | M | 60 | 3 years | |
| Jun Li He | M | 49 | 3 years | |
| Shun Fu Hu | M | - | - | |
| Ronald Packard | M | 60 | 1 years | |
| James Shmerling | M | 69 | 6 years | |
| Joseph Luis Damasio | M | 49 | 2 years | |
| Ting Li | M | 47 | 6 years | |
| Jason Jing Chen | M | 62 | 6 years | |
| Herman Sanchez | M | 49 | 3 years | |
| Hong Yu | M | 52 | 6 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| James J. McGorry | M | 67 | 7 years | |
| Thomas McNaughton | M | 63 | 7 years | |
| Adrienne D. Murano | F | - |
University of Connecticut
| 6 years |
| Marc Beer | M | 59 |
ViaCell, Inc.
 ViaCell, Inc. Medical SpecialtiesHealth Technology ViaCell, Inc. provides and develops cellular medicine for the treatment of diseases. The firm develops medicines for treatment of cancer, genetic disorders, organ transplant tolerance, neurological disorders, and autoimmune diseases. The company was founded in April 2000 and is headquartered in Cambridge, MA. | 7 years |
| John F. Kennedy | M | 75 | 6 years | |
| Peter M. Chakoutis | M | 59 | - | |
| Wei Zhang | M | 52 | 3 years | |
| Blaine McKee | M | 59 | 2 years | |
| Alfred A. Buchetto | M | - |
University of Connecticut
| 2 years |
| Jeffrey E. Young | M | 51 | 2 years | |
| John J. Canepa | M | 68 | 5 years | |
| Matthew D. Dallas | M | 49 | 2 years | |
| Saverio la Francesca | M | 62 | 3 years | |
| Jessica Parkhurst Kurys | F | - |
University of Connecticut
| 5 years |
| James Mastridge | M | 58 | 1 years | |
| Thomas H. Robinson | M | 65 | 6 years | |
| Peter A. Pellegrino | M | 49 | - | |
| Marius Jurgilas | M | 44 |
University of Connecticut
| 4 years |
| Michael Appell | M | - |
University of Connecticut
| 2 years |
| Mike Colonnese | M | - |
University of Connecticut
| 4 years |
| Rebecca Lobo | F | - |
University of Connecticut
| - |
| Jim Cracraft | M | - |
University of Connecticut
| 2 years |
| Rob Amenta | M | - |
University of Connecticut
| 4 years |
| Daniel J. Innamorato | M | - |
University of Connecticut
| 4 years |
| Tom Briney | M | - |
University of Connecticut
| 4 years |
| Amanda Birdsey-Benson | M | - |
University of Connecticut
| 4 years |
| Cem Akgün | M | 39 |
University of Connecticut
| 4 years |
| Ben Harshbarger | M | 55 |
ViaCell, Inc.
ViaCell, Inc. Medical SpecialtiesHealth Technology ViaCell, Inc. provides and develops cellular medicine for the treatment of diseases. The firm develops medicines for treatment of cancer, genetic disorders, organ transplant tolerance, neurological disorders, and autoimmune diseases. The company was founded in April 2000 and is headquartered in Cambridge, MA. | 2 years |
| Jun Dong | M | 47 |
University of Connecticut
| 2 years |
| Michael Scott Yudowitch | M | - |
University of Connecticut
| 4 years |
| Rebecca Elise Cioban | F | - |
University of Connecticut
| 4 years |
| Haluk Görgün | M | 51 |
University of Connecticut
| 1 years |
| Caleb Tripp | M | 38 |
University of Connecticut
| 4 years |
| Bevin Erickson | F | - |
University of Connecticut
| 2 years |
| Yi Yang | M | - |
University of Connecticut
| 3 years |
| Paul Amodeo | M | - |
University of Connecticut
| 4 years |
| Carrie Hart | F | - |
University of Connecticut
| 5 years |
| Bobby Narvaez | M | - |
University of Connecticut
| 4 years |
| Mathew Wallace | M | - |
University of Connecticut
| 4 years |
| Savvas Karamanlidis | M | - |
University of Connecticut
| 4 years |
| Montes Piard | M | - |
University of Connecticut
| 2 years |
| Feng Liu | M | 55 |
University of Connecticut
| 3 years |
| Curtis Dubay | M | - |
University of Connecticut
| 1 years |
| Noah J Sabich | M | - |
University of Connecticut
| 2 years |
| Frank R. Martire | M | 45 |
University of Connecticut
| 3 years |
| Brian Schmidt | M | - |
University of Connecticut
| 4 years |
| Bishen Pertab | M | - |
University of Connecticut
| 2 years |
| Lynn Dombrowski | F | 38 |
University of Connecticut
| 4 years |
| Kathleen Hayes | F | - |
ViaCell, Inc.
ViaCell, Inc. Medical SpecialtiesHealth Technology ViaCell, Inc. provides and develops cellular medicine for the treatment of diseases. The firm develops medicines for treatment of cancer, genetic disorders, organ transplant tolerance, neurological disorders, and autoimmune diseases. The company was founded in April 2000 and is headquartered in Cambridge, MA. | 4 years |
| Fallon Carla DePina | F | - |
University of Connecticut
| 3 years |
| Anne Cook | F | 62 |
ViaCell, Inc.
ViaCell, Inc. Medical SpecialtiesHealth Technology ViaCell, Inc. provides and develops cellular medicine for the treatment of diseases. The firm develops medicines for treatment of cancer, genetic disorders, organ transplant tolerance, neurological disorders, and autoimmune diseases. The company was founded in April 2000 and is headquartered in Cambridge, MA. | 2 years |
| Amanda E. Abdella | F | - |
University of Connecticut
| 4 years |
| Paul Blake | M | 76 |
ViaCell, Inc.
ViaCell, Inc. Medical SpecialtiesHealth Technology ViaCell, Inc. provides and develops cellular medicine for the treatment of diseases. The firm develops medicines for treatment of cancer, genetic disorders, organ transplant tolerance, neurological disorders, and autoimmune diseases. The company was founded in April 2000 and is headquartered in Cambridge, MA. | 2 years |
| Barbara Bierer | M | 70 |
ViaCell, Inc.
ViaCell, Inc. Medical SpecialtiesHealth Technology ViaCell, Inc. provides and develops cellular medicine for the treatment of diseases. The firm develops medicines for treatment of cancer, genetic disorders, organ transplant tolerance, neurological disorders, and autoimmune diseases. The company was founded in April 2000 and is headquartered in Cambridge, MA. | 2 years |
| Amy Cameron | F | - |
University of Connecticut
| 3 years |
| James L. Corbett | M | 61 |
ViaCell, Inc.
ViaCell, Inc. Medical SpecialtiesHealth Technology ViaCell, Inc. provides and develops cellular medicine for the treatment of diseases. The firm develops medicines for treatment of cancer, genetic disorders, organ transplant tolerance, neurological disorders, and autoimmune diseases. The company was founded in April 2000 and is headquartered in Cambridge, MA. | - |
| Denise Scots-Knight | M | 64 |
ViaCell, Inc.
ViaCell, Inc. Medical SpecialtiesHealth Technology ViaCell, Inc. provides and develops cellular medicine for the treatment of diseases. The firm develops medicines for treatment of cancer, genetic disorders, organ transplant tolerance, neurological disorders, and autoimmune diseases. The company was founded in April 2000 and is headquartered in Cambridge, MA. | - |
| Peter S. Drotch | M | 82 |
University of Connecticut
| 9 years |
| Paul Hastings | M | 64 |
ViaCell, Inc.
ViaCell, Inc. Medical SpecialtiesHealth Technology ViaCell, Inc. provides and develops cellular medicine for the treatment of diseases. The firm develops medicines for treatment of cancer, genetic disorders, organ transplant tolerance, neurological disorders, and autoimmune diseases. The company was founded in April 2000 and is headquartered in Cambridge, MA. | 7 years |
| Lawrence A. Zimbalist | M | - |
University of Connecticut
| 2 years |
| Adam Poussard | M | 40 |
University of Connecticut
| 4 years |
| Stephan Wnendt | M | 61 |
ViaCell, Inc.
ViaCell, Inc. Medical SpecialtiesHealth Technology ViaCell, Inc. provides and develops cellular medicine for the treatment of diseases. The firm develops medicines for treatment of cancer, genetic disorders, organ transplant tolerance, neurological disorders, and autoimmune diseases. The company was founded in April 2000 and is headquartered in Cambridge, MA. | - |
| Steve G. Dance | M | 72 |
ViaCell, Inc.
ViaCell, Inc. Medical SpecialtiesHealth Technology ViaCell, Inc. provides and develops cellular medicine for the treatment of diseases. The firm develops medicines for treatment of cancer, genetic disorders, organ transplant tolerance, neurological disorders, and autoimmune diseases. The company was founded in April 2000 and is headquartered in Cambridge, MA. | 3 years |
| Vaughn M. Kailian | M | 79 |
ViaCell, Inc.
ViaCell, Inc. Medical SpecialtiesHealth Technology ViaCell, Inc. provides and develops cellular medicine for the treatment of diseases. The firm develops medicines for treatment of cancer, genetic disorders, organ transplant tolerance, neurological disorders, and autoimmune diseases. The company was founded in April 2000 and is headquartered in Cambridge, MA. | 3 years |
| James S. Sigler | M | 63 |
ViaCell, Inc.
ViaCell, Inc. Medical SpecialtiesHealth Technology ViaCell, Inc. provides and develops cellular medicine for the treatment of diseases. The firm develops medicines for treatment of cancer, genetic disorders, organ transplant tolerance, neurological disorders, and autoimmune diseases. The company was founded in April 2000 and is headquartered in Cambridge, MA. | 2 years |
| John Thero | M | 63 |
ViaCell, Inc.
ViaCell, Inc. Medical SpecialtiesHealth Technology ViaCell, Inc. provides and develops cellular medicine for the treatment of diseases. The firm develops medicines for treatment of cancer, genetic disorders, organ transplant tolerance, neurological disorders, and autoimmune diseases. The company was founded in April 2000 and is headquartered in Cambridge, MA. | - |
| Jan van Heek | M | 75 |
ViaCell, Inc.
ViaCell, Inc. Medical SpecialtiesHealth Technology ViaCell, Inc. provides and develops cellular medicine for the treatment of diseases. The firm develops medicines for treatment of cancer, genetic disorders, organ transplant tolerance, neurological disorders, and autoimmune diseases. The company was founded in April 2000 and is headquartered in Cambridge, MA. | 5 years |
| James Tullis | M | 76 |
ViaCell, Inc.
ViaCell, Inc. Medical SpecialtiesHealth Technology ViaCell, Inc. provides and develops cellular medicine for the treatment of diseases. The firm develops medicines for treatment of cancer, genetic disorders, organ transplant tolerance, neurological disorders, and autoimmune diseases. The company was founded in April 2000 and is headquartered in Cambridge, MA. | 2 years |
| Igor A. Sherman | M | - |
University of Connecticut
| 4 years |
| Kirk T. Williamson | M | - |
ViaCell, Inc.
ViaCell, Inc. Medical SpecialtiesHealth Technology ViaCell, Inc. provides and develops cellular medicine for the treatment of diseases. The firm develops medicines for treatment of cancer, genetic disorders, organ transplant tolerance, neurological disorders, and autoimmune diseases. The company was founded in April 2000 and is headquartered in Cambridge, MA. | - |
| Celeste Moorehead | F | - |
University of Connecticut
| 4 years |
| Melissa Valcovic | F | - |
University of Connecticut
| 4 years |
| Daniel Faiman | M | 43 |
University of Connecticut
| 4 years |
| Da-Gon Chen | M | - |
University of Connecticut
| 2 years |
| Roger A. Gelfenbien | M | 80 |
University of Connecticut
| 6 years |
| Kelli Francis | F | - |
University of Connecticut
| 4 years |
| Aaron Haas Woomer | M | - |
University of Connecticut
| 4 years |
| Dan Volz | M | - |
University of Connecticut
| 4 years |
| Renee Montgomery | F | - |
University of Connecticut
| 4 years |
| Dana K. O'Brien | F | - |
University of Connecticut
| 3 years |
| Kevin McAdam | M | - |
University of Connecticut
| 1 years |
| Luigi Nicolais | M | 82 |
University of Connecticut
| 18 years |
| Trevor Russo | M | - |
University of Connecticut
| 4 years |
| Revisson R. Bonfim | M | - |
University of Connecticut
| 2 years |
| Tim Braziler | M | - |
University of Connecticut
| 4 years |
| Christin Cifaldi | F | - |
University of Connecticut
| 4 years |
| Rob Walch | M | - |
University of Connecticut
| 2 years |
| Jeff J. Kohler | M | - |
University of Connecticut
| 2 years |
| Amelia Stoj | F | - |
University of Connecticut
| 3 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 99 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- William Fodor
- Personal Network
